Literature DB >> 3053871

The use of metronidazole (Flagyl) in Crohn's disease.

R R Babb1.   

Abstract

The efficacy of metronidazole in the treatment of Crohn's disease remains unproven. It has not been superior to a placebo in three small studies. Uncontrolled reports suggest it may be of benefit in selected patients who have not responded to previous medical or surgical therapy. Metronidazole therapy can lead to complete healing of perineal fistulas. Persistent concerns over side-effects, carcinogenicity, and bacterial resistance suggest that drug should be prescribed with caution for long-term use.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3053871     DOI: 10.1097/00004836-198810000-00002

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  1 in total

1.  Double blind, placebo controlled trial of metronidazole in Crohn's disease.

Authors:  L Sutherland; J Singleton; J Sessions; S Hanauer; E Krawitt; G Rankin; R Summers; H Mekhjian; N Greenberger; M Kelly
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.